Acute systemic inflammation increases arterial stiffness and decreases wave reflections in healthy individuals

被引:392
作者
Vlachopoulos, C [1 ]
Dima, I [1 ]
Aznaouridis, K [1 ]
Vasiliadou, C [1 ]
Ioakeimidis, N [1 ]
Aggeli, C [1 ]
Toutouza, M [1 ]
Stefanadis, C [1 ]
机构
[1] Hippokrateion Hosp, Athens Med Sch, Dept Cardiol 1, Athens, Greece
关键词
arterial stiffness; atherosclerosis; endothelium; inflammation; wave reflections;
D O I
10.1161/CIRCULATIONAHA.105.535435
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-Aortic stiffness is a marker of cardiovascular disease and an independent predictor of cardiovascular risk. Although an association between inflammatory markers and increased arterial stiffness has been suggested, the causative relationship between inflammation and arterial stiffness has not been investigated. Methods and Results-One hundred healthy individuals were studied according to a randomized, double-blind, sham procedure-controlled design. Each substudy consisted of 2 treatment arms, 1 with Salmonella typhi vaccination and 1 with sham vaccination. Vaccination produced a significant ( P < 0.01) increase in pulse wave velocity ( at 8 hours by 0.43 m/s), denoting an increase in aortic stiffness. Wave reflections were reduced significantly ( P < 0.01) by vaccination ( decrease in augmentation index of 5.0% at 8 hours and 2.5% at 32 hours) as a result of peripheral vasodilatation. These effects were associated with significant increases in inflammatory markers such as high-sensitivity C-reactive protein ( P < 0.001), high-sensitivity interleukin- 6 ( P < 0.001), and matrix metalloproteinase-9 ( P < 0.01). With aspirin pretreatment ( 1200 mg PO), neither pulse wave velocity nor augmentation index changed significantly after vaccination ( increase of 0.11 m/s and 0.4%, respectively; P = NS for both). Conclusions-This is the first study to show through a cause-and-effect relationship that acute systemic inflammation leads to deterioration of large-artery stiffness and to a decrease in wave reflections. These findings have important implications, given the importance of aortic stiffness for cardiovascular function and risk and the potential of therapeutic interventions with antiinflammatory properties.
引用
收藏
页码:2193 / 2200
页数:8
相关论文
共 43 条
[1]   Soluble CD14 and aortic stiffness in a population-based study [J].
Amar, J ;
Ruidavets, JB ;
Sollier, CBD ;
Bongard, V ;
Boccalon, H ;
Chamontin, B ;
Drouet, L ;
Ferrières, J .
JOURNAL OF HYPERTENSION, 2003, 21 (10) :1869-1877
[2]   ASSESSMENT OF ARTERIAL DISTENSIBILITY BY AUTOMATIC PULSE-WAVE VELOCITY-MEASUREMENT - VALIDATION AND CLINICAL-APPLICATION STUDIES [J].
ASMAR, R ;
BENETOS, A ;
TOPOUCHIAN, J ;
LAURENT, P ;
PANNIER, B ;
BRISAC, AM ;
TARGET, R ;
LEVY, BI .
HYPERTENSION, 1995, 26 (03) :485-490
[3]   Cytokine-induced venodilatation in humans in vivo: eNOS masquerading as iNOS [J].
Bhagat, K ;
Hingorani, AD ;
Palacios, M ;
Charles, IG ;
Vallance, P .
CARDIOVASCULAR RESEARCH, 1999, 41 (03) :754-764
[4]  
Bhagat K, 1996, CARDIOVASC RES, V32, P822
[5]   Inflammatory cytokines impair endothelium-dependent dilatation in human veins in vivo [J].
Bhagat, K ;
Vallance, P .
CIRCULATION, 1997, 96 (09) :3042-3047
[6]   Increasing levels of interleukin (IL)-1Ra and IL-6 during the first 2 days of hospitalization in unstable angina are associated with increased risk of in-hospital coronary events [J].
Biasucci, LM ;
Liuzzo, G ;
Fantuzzi, G ;
Caligiuri, G ;
Rebuzzi, AG ;
Ginnetti, F ;
Dinarello, CA ;
Maseri, A .
CIRCULATION, 1999, 99 (16) :2079-2084
[7]   Aortic pulse wave velocity as a marker of cardiovascular risk in hypertensive patients [J].
Blacher, J ;
Asmar, R ;
Djane, S ;
London, GM ;
Safar, ME .
HYPERTENSION, 1999, 33 (05) :1111-1117
[8]   C-reactive protein and other inflammatory risk markers in acute coronary syndromes [J].
Blake, GJ ;
Ridker, PM .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (04) :37S-42S
[9]  
Chen CH, 1997, CIRCULATION, V95, P1827
[10]   Inflammation and endothelial function - Direct vascular effects of human C-reactive protein on nitric oxide bioavailability [J].
Clapp, BR ;
Hirschfield, GM ;
Storry, C ;
Gallimore, JR ;
Stidwill, RP ;
Singer, M ;
Deanfield, JE ;
MacAllister, RJ ;
Pepys, MB ;
Vallance, P ;
Hingorani, AD .
CIRCULATION, 2005, 111 (12) :1530-1536